Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aura Biosciences (AURA) Share-based Compensation (2020 - 2026)

Aura Biosciences filings provide 7 years of Share-based Compensation readings, the most recent being $3.8 million for Q1 2026.

  • Quarterly Share-based Compensation rose 8.82% to $3.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $14.6 million through Mar 2026, up 18.66% year-over-year, with the annual reading at $14.3 million for FY2025, 22.14% up from the prior year.
  • Share-based Compensation hit $3.8 million in Q1 2026 for Aura Biosciences, up from $3.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $3.8 million in Q2 2025 and bottomed at $1.3 million in Q2 2022.
  • Average Share-based Compensation over 5 years is $2.6 million, with a median of $2.8 million recorded in 2024.
  • The largest annual shift saw Share-based Compensation soared 761.62% in 2022 before it grew 8.82% in 2026.
  • Aura Biosciences' Share-based Compensation stood at $1.8 million in 2022, then surged by 43.5% to $2.6 million in 2023, then increased by 12.83% to $2.9 million in 2024, then rose by 11.75% to $3.3 million in 2025, then increased by 16.51% to $3.8 million in 2026.
  • Per Business Quant, the three most recent readings for AURA's Share-based Compensation are $3.8 million (Q1 2026), $3.3 million (Q4 2025), and $3.7 million (Q3 2025).